|
|
Volumn 18, Issue 12, 2012, Pages 1718-1719
|
|
Gene therapies advance, but some see manufacturing challenges
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG CONTAMINATION;
DRUG DESIGN;
GENE THERAPY;
GENE VECTOR;
METABOLISM;
METHODOLOGY;
NOTE;
PHARMACEUTICS;
STANDARD;
DRUG CONTAMINATION;
DRUG DESIGN;
GENETIC THERAPY;
GENETIC VECTORS;
TECHNOLOGY, PHARMACEUTICAL;
|
|
EID: 84873498637
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm1212-1718 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|